2Braungart E, Magdolen V, Degitz K.Retinoic acid upregulates the plasminogen activator system in human epidermal keratinocytes[J].J Invest Dermatol,2001,116(5):778-784.
3Villarreal EC. Current and potential therapies for the treatment of herpes-virus infections[J].Prog Drug Res,2003,60(1): 263-307.
6Shen MC, Lin HH, Lee SS, et al. Double-blind, randomized, acyclovircontrolled, parallel-group trial comparing the safety and efficacy of famciclovir and acyelovir in patients with uncomplicated herpes zoster. J Microbiol Immunol Infect 2004 ;37(2):75-81.
5Shen MC,Lin HH,Lee SS,et al.Double-Blind,randomizied acyclovir-controlled,paralle-group trial compairing the safety and efficacy of famciclovir and acyclovir in patients with un-complicated herpes zostder[J].J Microbiol Immunol Infect,2004,37(2):75-81.
6杨慧兰.病毒性皮肤病学[M]北京:人民军医出版社,2009159-166.
7Munksgaard B. Cytomegalovirus[J]. Am J Transplant, 2004, 4 (Suppl 10): s51-58.
8Mouloudi E, Massa E, Georgiadou E, et al. Infectionsrelated to renal transplantation requiring intensive care admission: a 20-year study[J]. Transplant Proc, 2012, 44(9): 2721-2723.
9Fishman J A, Emery V, Freeman R, et al. Cytomegalovirus in transplantation-challenging the status quo[J]. Clin Transplant, 2007, 21(2): 149-158.
10Wang Y, Smith K E Safety of alternative antiviral agents for neonatal herpes simplex virus encephalitis and disseminated infection[J]. JPediatr Pharmacol Ther, 2014, 19(2): 72-82.
